| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |